Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




3D-Printed Blood Vessels Could Improve Outcomes for Heart Bypass Patients

By HospiMedica International staff writers
Posted on 29 Jul 2024

Strong, flexible, gel-like tubes developed through innovative 3D printing technology could improve heart bypass surgery outcomes, replacing the human and synthetic veins currently used to divert blood flow, according to experts. More...

The creation of synthetic vessels can reduce scarring, pain, and infection risks linked to the extraction of human veins in bypass procedures. These products could also address the shortcomings of small synthetic grafts, which often struggle to integrate into the body, according to research published in Advanced Materials Technologies.

A research team led by The University of Edinburgh’s School of Engineering (Edinburgh, UK) employed a two-stage technique, integrating a rotating spindle with a 3D printer to fabricate tubular grafts from a water-based gel. This printed graft was reinforced using a process known as electrospinning, which utilizes high voltage to produce extremely fine nanofibers, thus coating the artificial blood vessel with biodegradable polyester molecules. Tests have confirmed that these products match the strength of natural blood vessels. The grafts, adjustable in diameters from 1 to 40 mm, are versatile for various applications, and their flexibility facilitates easy integration into the human body, according to the team. Future research phases will test these synthetic blood vessels in animal studies, with subsequent human trials planned.

“The results from our research address a long-standing challenge in the field of vascular tissue engineering – to produce a conduit that has similar biomechanical properties to that of human veins,” said Dr. Norbert Radacsi, Principal investigator, School of Engineering, University of Edinburgh. “With continued support and collaboration, the vision of improved treatment options for patients with cardiovascular disease could become a reality.”

Related Links:
The University of Edinburgh’s School of Engineering


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.